We believe that better models of human disease lead to identification of meaningful drug targets and discovery of successful new drug treatments.

RARE DISEASE DAY.

Hemoshear works hard every day to advance critical research for challenging diseases. This February, our team is stepping out to support NORD’s Rare Disease Day Movement to bike, run or walk 7,000 Miles to help raise money for the 30 million Americans who need new treatments.

Partnership has generated several early drug discovery therapeutic targets that experimentally inhibit biological processes that may lead to nonalcoholic steatohepatitis (NASH), cirrhosis, and liver cancer.